Yumanity Therapeutics, Inc.(Yumanity) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced it has entered into definitive agreements for two strategic transactions.
https://sports.yahoo.com/yumanity-therapeutics-announces-definitive-agreements-103000748.html